Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Gynecol Oncol. 2021 Aug 25;163(2):334–341. doi: 10.1016/j.ygyno.2021.08.014

Figure 2: Bystander assay-.

Figure 2:

Solid gray bar no-border: Low/negative HER2/neu expressing ARK4 cell (ARK4-GFP cells), co-cultured without any treatment (control, CTRL). Stripes bar with no-border: Low/negative HER2/neu expressing ARK4 cell (ARK4-GFP cells), co-cultured with high HER2/neu expressing cells (ARK2) and treated with control ADC at 1 μg/mL. Squares bar no-border: Low/negative HER2/neu expressing ARK4 cell (ARK4-GFP cells), co-cultured with high HER2/neu expressing cells (ARK2) and treated with DHES0815A at 1 μg/mL concentration.